By PTI NEW DELHI: Bharat Biotech’s COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged...
Bharat Biotech
By PTI NEW DELHI: A PIL in the Delhi High Court on Tuesday sought a direction to the Centre to waive clinical trials of foreign...
By PTI NEW DELHI: Bharat Biotech on Thursday announced a cut in the price of its COVID-19 vaccine ‘Covaxin’ it plans to sell to...
Many states have objected to different prices for the vaccines, with Delhi Chief Minister Arvind Kejriwal saying this is not time for profiteering.
By PTI NEW DELHI: Bharat Biotech has written to the India’s drug regulator seeking extension of the shelf-life of its indigenously developed COVID-19 vaccine...
By Express News Service NEW DELHI: Hyderabad-based Bharat Biotech on Saturday announced that its COVID-19 vaccine, Covaxin will cost Rs 600 per dose to...
Express News Service NEW DELHI: A day after the Centre liberalised its Covid-19 vaccination policy, allowing states to procure doses directly from the manufacturers...
Express News Service NEW DELHI: Bharat Biotech and ICMR on Wednesday announced results of the phase 3 efficacy trial of Covaxin, India’s first and...
Express News Service NEW DELHI: A day after the Centre liberalised its Covid-19 vaccination policy, allowing states to procure doses directly from the manufacturers...
By PTI NEW DELHI: To support vaccination campaigns in India and across the globe, Bharat Biotech has ramped up the manufacturing capacity of its...